Beyond first implant: valve-in-valve, redo and leaflet modification

Session comprising selected EuroPCR 2026 abstract submissions

Summary

This session explores advanced transcatheter aortic valve therapies beyond the first implant, focusing on valve-in-valve, redo procedures, and leaflet modification techniques. Topics include bioprosthetic valve fracture, long-term outcomes from the DURA-ViV registry, simplified workflows for leaflet modification in redo-TAVI, and intravascular ultrasound evaluation of valve expansion and geometry, providing a comprehensive overview of complex valve management strategies.

Presentations available when logged in:

  • Bioprosthetic valve fracture and modification in small surgical valve ViV-TAVI: long-term outcomes
  • Thirty-day outcomes of valve-in-valve with Navitor for failed surgical aortic bioprosthetic valves
  • “Knowing where to split”: a simplified workflow to plan and guide leaflet modification in redo-TAVI
  • Durability and long-term outcomes of valve-in-valve TAVI: the DURA-ViV registry
  • Clinical outcomes of redo TAVI according to computed tomography sizing
  • Evaluation of transcatheter aortic valve expansion and geometry using intravascular ultrasound